Published in

Elsevier, Translational Oncology, (31), p. 101637, 2023

DOI: 10.1016/j.tranon.2023.101637

Links

Tools

Export citation

Search in Google Scholar

Osimertinib Improves overall survival of EGFR-mutant NSCLC patients with leptomeningeal metastases

This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Green circle
Preprint: archiving allowed
Green circle
Postprint: archiving allowed
Green circle
Published version: archiving allowed
Data provided by SHERPA/RoMEO